S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
NASDAQ:MASI

Masimo Stock Forecast, Price & News

$223.65
-9.43 (-4.05%)
(As of 01/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$223.42
$229.49
50-Day Range
$233.08
$303.29
52-Week Range
$205.10
$305.21
Volume
309,332 shs
Average Volume
388,962 shs
Market Capitalization
$12.35 billion
P/E Ratio
55.77
Dividend Yield
N/A
Beta
0.73
30 days | 90 days | 365 days | Advanced Chart
Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.


Masimo logo

About Masimo

Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Headlines

Masimo Co. (NASDAQ:MASI) Director Sells $150,006.00 in Stock
January 12, 2022 |  americanbankingnews.com
Masimo sees FY21 revenue growth of 8% - Seeking Alpha
January 12, 2022 |  seekingalpha.com
Masimo (NASDAQ:MASI) Updates FY21 Earnings Guidance
January 11, 2022 |  americanbankingnews.com
Masimo sees FY21 revenue growth of 8%
January 11, 2022 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:MASI
CUSIP
57479510
Employees
5,300
Year Founded
1989

Sales & Book Value

Annual Sales
$1.14 billion
Cash Flow
$4.14 per share
Book Value
$25.47 per share

Profitability

Net Income
$240.30 million
Pretax Margin
21.91%

Debt

Price-To-Earnings

Miscellaneous

Free Float
50,197,000
Market Cap
$12.35 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/25/2021
Today
1/19/2022
Next Earnings (Confirmed)
2/15/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.32 out of 5 stars

Medical Sector

255th out of 1,414 stocks

Electromedical Equipment Industry

5th out of 29 stocks

Analyst Opinion: 3.3Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -












Masimo (NASDAQ:MASI) Frequently Asked Questions

Is Masimo a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Masimo stock.
View analyst ratings for Masimo
or view top-rated stocks.

How has Masimo's stock price been impacted by Coronavirus?

Masimo's stock was trading at $182.64 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MASI stock has increased by 22.5% and is now trading at $223.65.
View which stocks have been most impacted by COVID-19
.

When is Masimo's next earnings date?

Masimo is scheduled to release its next quarterly earnings announcement on Tuesday, February 15th 2022.
View our earnings forecast for Masimo
.

How can I listen to Masimo's earnings call?

Masimo will be holding an earnings conference call on Tuesday, February 15th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) announced its quarterly earnings data on Monday, October, 25th. The medical equipment provider reported $0.94 EPS for the quarter, beating the consensus estimate of $0.91 by $0.03. The medical equipment provider earned $307.40 million during the quarter, compared to analyst estimates of $295.79 million. Masimo had a net margin of 19.23% and a trailing twelve-month return on equity of 15.56%. The business's quarterly revenue was up 10.5% compared to the same quarter last year. During the same period last year, the business posted $0.80 earnings per share.
View Masimo's earnings history
.

What guidance has Masimo issued on next quarter's earnings?

Masimo updated its FY22 earnings guidance on Tuesday, January, 11th. The company provided earnings per share guidance of $4.34 for the period, compared to the Thomson Reuters consensus estimate of $4.35. The company issued revenue guidance of $1.35 billion, compared to the consensus revenue estimate of $1.35 billion.

What price target have analysts set for MASI?

3 equities research analysts have issued twelve-month price targets for Masimo's stock. Their forecasts range from $285.00 to $330.00. On average, they anticipate Masimo's share price to reach $308.33 in the next year. This suggests a possible upside of 37.9% from the stock's current price.
View analysts' price targets for Masimo
or view top-rated stocks among Wall Street analysts.

Who are Masimo's key executives?

Masimo's management team includes the following people:
  • Joe E. Kiani, Chairman & Chief Executive Officer
  • Bilal Muhsin, Chief Operating Officer
  • Micah Young, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
  • Yongsam Lee, Chief Information Officer & Executive VP
  • Anand Sampath, Executive VP-Operations & Clinical Research

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo CEO Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among Masimo's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by many different institutional and retail investors. Top institutional investors include Vaughan Nelson Investment Management L.P. (1.35%), Scout Investments Inc. (0.12%), State of Alaska Department of Revenue (0.06%), Royal London Asset Management Ltd. (0.03%), Louisiana State Employees Retirement System (0.02%) and Exchange Traded Concepts LLC (0.02%). Company insiders that own Masimo stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Steven Barker, Tao Levy, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends for Masimo
.

Which major investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., Exchange Traded Concepts LLC, Scout Investments Inc., Crossmark Global Holdings Inc., Diversified Trust Co, Spire Wealth Management, Tributary Capital Management LLC, and West Oak Capital LLC. Company insiders that have sold Masimo company stock in the last year include Adam Mikkelson, Joe E Kiani, Micah W Young, and Tao Levy.
View insider buying and selling activity for Masimo
or view top insider-selling stocks.

Which major investors are buying Masimo stock?

MASI stock was bought by a variety of institutional investors in the last quarter, including HighTower Trust Services LTA, State of Alaska Department of Revenue, Royal London Asset Management Ltd., Louisiana State Employees Retirement System, and M&G Investment Management Ltd..
View insider buying and selling activity for Masimo
or or view top insider-buying stocks.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $223.65.

How much money does Masimo make?

Masimo has a market capitalization of $12.35 billion and generates $1.14 billion in revenue each year. The medical equipment provider earns $240.30 million in net income (profit) each year or $4.01 on an earnings per share basis.

How many employees does Masimo have?

Masimo employs 5,300 workers across the globe.

When was Masimo founded?

Masimo was founded in 1989.

What is Masimo's official website?

The official website for Masimo is www.masimo.com.

Where are Masimo's headquarters?

Masimo is headquartered at 52 DISCOVERY, IRVINE CA, 92618.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at (949) 297-7000, via email at [email protected], or via fax at 949-297-7001.


This page was last updated on 1/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.